The Pro Medicus Ltd (ASX: PME) share price is in focus after the company announced a binding Heads of Agreement with Echo IQ for a finance facility and reseller agreement, aiming to expand its AI-driven cardiology solutions.

What did Pro Medicus report?

• Signed a binding Heads of Agreement with Echo IQ Ltd for a financing arrangement
• Agreement includes a reseller arrangement for Echo IQ’s AI algorithms in cardiology
• Focus on commercialising solutions for aortic stenosis and heart failure detection
• Definitive agreements expected within 20 business days or the transaction may lapse

What else do investors need to know?

Pro Medicus is broadening its AI strategy by adding third-party algorithms to its Visage 7 Cardiology platform, alongside in-house and partner-developed solutions. The finance facility for Echo IQ is designed to help accelerate its AI offerings, particularly in key disease areas.

While the Heads of Agreement sets out the framework, the deal is subject to final legal agreements. Pro Medicus has committed to updating shareholders once these are completed or if negotiations end without a deal.

What did Pro Medicus management say?

Chief Executive Officer Dr Sam Hupert said:

In addition to providing financial backing, we are looking to offer our Visage 7 Cardiology customers the option of Echo IQ’s technology. This is in line with our AI strategy of offering a curated suite of algorithms that will be a mixture of algorithms created by us, those created in conjunction with our clinical partners and 3rd party algorithms such as Echo-IQ.

What’s next for Pro Medicus?

Pro Medicus plans to proceed with negotiating definitive agreements with Echo IQ over the next 20 business days. The move supports its ambition to grow market offerings and provide innovative, AI-powered cardiology solutions to its customers.

If successful, the agreement will further expand Pro Medicus’ AI capabilities and commercial reach, reinforcing its growth strategy in health imaging.

Pro Medicus share price snapshot

Over the past 12 months, Pro Medicus shares have declined 35%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

The post Pro Medicus signs Echo IQ deal to boost AI cardiology offering appeared first on The Motley Fool Australia.

More reading

• Ventia Services appoints new CEO in leadership succession
• A2 Milk declares $300 million special dividend after securing China approval
• 2 ASX 200 shares I’d buy for powerful growth
• 5 things to watch on the ASX 200 on Thursday
• 3 buy-rated ASX tech shares with bright futures

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Ventia Services Group Ltd (ASX: VNT) share price is in focus after the company announced Mark Ralston will succeed Dean Banks as Managing Director and Group CEO from 1 September 2026, following a comprehensive succession process.

What did Ventia report?

• Appointment of Mark Ralston as incoming Managing Director and Group Chief Executive Officer, effective 1 September 2026
• Mark Ralston has over 12 years’ experience at Ventia, leading major business sectors including Defence & Social Infrastructure
• Current CEO Dean Banks to support a seamless leadership transition before stepping down
• Mr Ralston’s remuneration set at A$1.1 million per annum plus incentives
• Shareholder approval required for LTI grant at the 2027 AGM

What else do investors need to know?

The board highlighted that Ralston’s appointment follows an extensive internal and external search, underlining the strength of Ventia’s internal leadership pipeline. Ralston has built deep insight into Ventia’s operations, customers, and markets through a variety of influential roles across the business.

Chairman David Moffatt acknowledged outgoing CEO Dean Banks for strengthening the organisation’s position over the past five years. Moffatt said the board looks forward to Ralston ensuring “continuity in the execution of Ventia’s strategy and ongoing focus on delivering for our customers and shareholders.”

What’s next for Ventia?

Investors can expect a period of stable transition as Ralston is set to work closely with Banks until September, ensuring business continuity. The board intends for the new appointment to support a seamless evolution of Ventia’s long-term customer-focused and innovative strategy.

With operations spanning across key infrastructure segments and a workforce of over 35,000, Ventia aims to maintain its commitment to service excellence and sustainable growth as it enters this new chapter.

Ventia share price snapshot

Over the past 12 months, Ventia Services shares have risen 34%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

The post Ventia Services appoints new CEO in leadership succession appeared first on The Motley Fool Australia.

More reading

• Pro Medicus signs Echo IQ deal to boost AI cardiology offering
• A2 Milk declares $300 million special dividend after securing China approval
• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• Metrics Master Income Trust announces June 2026 monthly payout

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Rio Tinto Ltd (ASX: RIO) shares closed around 1% lower on Wednesday afternoon, at $173.92 a piece.

This latest trade price means Rio Tinto shares have now fallen around 11% from an all-time high of $194.47 recorded in early June. 

But it’s still been an incredible success story for the ASX mining stock recently. Even after cooling from a record high, its shares are still around 18% higher year to date and 66% higher than a year ago.

For context, the S&P/ASX 200 Index (ASX: XJO) closed around 0.2% higher on Wednesday afternoon and is up around 1% year to date.

So, if I bought $5,000 of Rio Tinto shares 12 months ago, what would it be worth today?

Rio Tinto shares were trading around $105 each this time last year, 66% lower than the share price at the time of writing.

That means your $5,000 investment 12 months ago would now be worth $8,300.

Can the miner’s shares return to record highs?

After an impressive rally over the past 12 months, it looks like Rio Tinto shares have now peaked.

Market Index data shows that the majority of brokers have a hold rating on the miner’s shares. But the latest $173.26 target price now implies a very minor 0.4% downside for Rio Tinto shares, at the time of writing.

TradingView data reflects something similar. Eight out of 16 analysts have a hold rating on the shares. Another six have a buy or strong buy rating, and two rate the shares as a strong sell.

The average $184.01 target price implies a potential 6% upside at the time of writing. Although some more bullish analysts still think the share price could increase another 24% to $215.32. Then the more bearish of the bunch forecast Rio Tinto shares to fall up to 16% to a minimum $145.84 price target, at the time of writing.

The team at Bell Potter are very bullish on Rio Tinto shares and believes that we’re only at the beginning of a sustained commodity supercycle. The broker also believes that Rio Tinto is the highest-quality way to gain exposure to copper and aluminium.

Meanwhile, Macquarie lifted its price target on the miner’s shares to $188 in mid-June and downgraded its stance to a hold rating.

The team at Morgans also has a hold rating on the shares. The broker thinks the miner’s balance sheet is strong and dividends are well-supported, but warns that the near-term earnings outlook looks balanced rather than clearly positive. 

The post If I’d invested $5,000 in Rio Tinto shares 12 months ago, guess what I’d have now! appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Why Aurelia Metals, Beach Energy, IAG, and Rio Tinto shares are falling today
• 5 things to watch on the ASX 200 on Wednesday
• Forget BHP and Rio Tinto, this ASX copper share could rise 100%+
• Which Aussie blue-chip stock is the best performer so far in 2026?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.